A 2023 national web-based survey assessed in-house and send-out infectious disease testing in 2,689 Chinese hospitals. Availability was compared with notified incidence and mortality. Median in-house coverage was 11.6% in primary, 27.9% in secondary and 39.5% in tertiary hospitals. Hepatitis B testing was near universal, but pulmonary tuberculosis testing ranged from 21% of primary to 83.7% of tertiary hospitals. Tertiary hospital availability was limited for hand, foot and mouth disease (35%), other infectious diarrhoeal diseases (42%) and rabies (4%). Only 124 primary hospitals took part, and capacity was reported by the hospitals themselves.
Why it is interesting: Uneven hospital testing capacity may affect which infectious disease cases are notified. This survey shows where local testing gaps sit against China's reported infectious disease burden.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.